Albert Bourla

Albert Bourla is a Greek-born pharmaceutical executive who has served as Chairman and Chief Executive Officer of Pfizer Inc. since January 2019. A Doctor of Veterinary Medicine with a Ph.D. in the Biotechnology of Reproduction from Aristotle University of Thessaloniki, Bourla joined Pfizer in 1993 in its animal health division in Greece and advanced through successive leadership roles in Europe and the United States, including as Chief Operating Officer from 2018.

Under Bourla's leadership, Pfizer collaborated with BioNTech to develop BNT162b2, the first mRNA-based COVID-19 vaccine authorized for emergency use by the U.S. FDA in December 2020 after a clinical trial demonstrating over 90% efficacy against symptomatic disease in initial strains. The vaccine's accelerated timeline—from candidate selection to authorization in under a year—leveraged parallel processes, prior mRNA research, and substantial investment, enabling billions of doses to be distributed globally and credited by some analyses with averting millions of deaths. However, subsequent data revealed waning efficacy against infection and transmission from variants like Omicron, contradicting earlier assertions by Bourla that the vaccine would largely prevent spread.

Albert Bourla was born Israel Abraham Bourla on October 21, 1961, in Thessaloniki, Greece, to Mois and Sara Bourla, members of the city's ancient Sephardic Jewish community whose ancestors had fled Spain following the Alhambra Decree in the late 15th century. Thessaloniki's pre-war Jewish population of approximately 50,000 was nearly eradicated during the Nazi occupation, with only around 2,000 survivors emerging afterward, representing a survival rate of about 4 percent. Bourla's parents were among those rare survivors, each having endured separate ordeals that decimated their families.

Bourla's parents, having lost nearly all relatives, emphasized resilience and the value of life in recounting their experiences, instructing him to remember the Holocaust not for hatred but to build a meaningful future. They placed strong importance on education as a means of advancement, with Mois Bourla holding two specific aspirations for his son: to become a scientist and to marry a Jewish woman. These familial legacies of survival and determination profoundly shaped Bourla's early worldview, fostering a commitment to empirical progress over dwelling on past traumas.

Albert Bourla is married to Myriam Bourla, with whom he has two children. His father, a Holocaust survivor, expressed two key aspirations for him: to become a scientist and to marry a "nice Jewish girl"; Bourla noted that his father lived to witness both. He fulfilled the latter by marrying in a synagogue, reflecting his family's Sephardic Jewish heritage.